Nyrada (ASX:NYR) Common Stock: A$38.19 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:NYR Nyrada Inc ASX:NYR
33 GF Score
Price A$0.58
! 1 Warning Sign
View Full Analysis

What is Nyrada Common Stock?

Nyrada ASX:NYR +38.55% 33 Common Stock is A$38.19 Mil as of Dec. 2025. GuruFocus rates ASX:NYR with a GF Score™ of 33/100. The stock has 1 warning sign investors should review.

Nyrada's quarterly common stock increased from Dec. 2024 (A$29.70 Mil) to Jun. 2025 (A$29.77 Mil) and increased from Jun. 2025 (A$29.77 Mil) to Dec. 2025 (A$38.19 Mil).

Nyrada's annual common stock increased from Jun. 2023 (A$25.32 Mil) to Jun. 2024 (A$26.84 Mil) and increased from Jun. 2024 (A$26.84 Mil) to Jun. 2025 (A$29.77 Mil).

Nyrada Common Stock Historical Data

* Premium members only.

The historical data trend for Nyrada's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nyrada Common Stock Chart

Nyrada Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial 25.32 25.32 25.32 26.84 29.77

Nyrada Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.32 26.84 29.70 29.77 38.19
ASX:NYR
33GF Score
Nyrada Inc ASX:NYR
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nyrada Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$38.19 Mil mean?
Nyrada (ASX:NYR) has a Common Stock of A$38.19 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nyrada and its competitors.
Is Nyrada's Common Stock too high?
Nyrada's current Common Stock is A$38.19 Mil. Overall, Nyrada has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Nyrada's Common Stock compare to VRTX and REGN?
Nyrada's Common Stock of A$38.19 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Nyrada and its competitors. Nyrada's current Common Stock is A$38.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nyrada stock overvalued right now?
Nyrada (ASX:NYR) has a current Common Stock of A$38.19 Mil. The current Common Stock is A$38.19 Mil. Nyrada's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Nyrada (ASX:NYR), the current Common Stock is A$38.19 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nyrada Business Description

Address 180 George Street, Sydney Place, Level 22/23, Salesforce Tower, Sydney, NSW, AUS, 2000
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. It operates in one segment: research and development of drugs focusing on small molecules with potential therapeutic benefit in areas of medical needs. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.
33GF Score

Get the complete analysis for ASX:NYR

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.58
Price